Melissa Hollo: Connecting Obesity and Anemia for Earlier Maternal Risk Intervention
Melissa Hollo, Director of Project Management at hc1 and Licensed Independent Clinical Social Worker, shared a post on LinkedIn:
“Two common maternal health risks. One opportunity to intervene earlier.
Obesity and anemia are often managed as separate issues but they can intersect in meaningful ways.
Maternal obesity is associated with increased risk of gestational diabetes, hypertension, preeclampsia, cesarean delivery, preterm birth and stillbirth.
Pregnancy related anemia is associated with increased risk of postpartum hemorrhage, preterm delivery, low birth weight, cesarean delivery and hypertensive disorders.
There is also a biologic connection worth paying attention to: obesity related inflammation can increase hepcidin, potentially reducing iron availability and maternal fetal iron transfer.
The opportunity is earlier identification and intervention.
Anemia and iron deficiency are identifiable and treatable. Metabolic health can also be addressed before and during pregnancy. When we bring these risk factors together, we have a better opportunity to support proactive, not reactive, maternal care.
This is the thinking behind hc1 Clinical IQ’s Maternal Health module (HerCare): using clinical intelligence to identify multiple maternal risks earlier and help clinicians intervene before risk becomes complication.
Better maternal outcomes start with identifying risk early enough to do something about it.”
Stay updated with Hemostasis Today.
-
Sep 23, 2026, 13:58The New B12 Diagnostic Algorithm: From Serum Cobalamin to Functional Deficiency
-
Sep 23, 2026, 13:56Noha Soror: Preparing for Hematology and Medical Oncology Board Certification
-
Sep 23, 2026, 13:46Ugochi Ogu: What Can Platelet Proteomics Reveal about Pain and Neurocognitive Vulnerability in Sickle Cell Disease?
-
Sep 23, 2026, 13:16Beverley Hunt: Advances in Haemostatic Management of Postpartum Haemorrhage
-
Sep 23, 2026, 13:13Ioanna Mela: Recruiting a Research Associate on DNA nanotechnology
-
Sep 23, 2026, 13:04Ben Samelson-Jones: Do Gene Variants Drive PK Differences in FIX-Fusion and N9-GP Therapies?
-
Sep 23, 2026, 12:57Shelly Reed: Advocating for HTCs and CDC Funding with the Hemophilia Federation of America
-
Sep 23, 2026, 12:51Domenico Girelli: How Verona Hospital Transformed ED Anemia Care with Patient Blood Management
-
Sep 23, 2026, 12:45Lina Camacho-Arteaga: ENTIS Study Uncovers Safety Data on Early Pregnancy Exposure to Direct Oral Anticoagulants